Investigation announced for Investors in Livongo Health, Inc. (NASDAQ: LVGO) over Takeover

An investigation was announced concerning whether the takeover of Livongo Health, Inc. is unfair to NASDAQ: LVGO stockholders.

Investors who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO) and currently hold any of those NASDAQ: LVGO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain directors of Livongo Health, Inc. breached their fiduciary duties owed to NASDAQ: LVGO investors in connection with the proposed acquisition.

Mountain View based Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. On August 05, 2020, Teladoc Health (NYSE: TDOC) and Livongo (NASDAQ: LVGO) announced that they have entered into a merger agreement. Under the terms of the agreement, each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of $11.33 for each Livongo share, representing a value of $18.5 billion based on the closing price of Teladoc Health shares as of August 4, 2020. Based on a closing price of $249.42 per NYSE: TDOC share on August 4, 2020, investors in shares of Livongo Health, Inc. (NASDAQ: LVGO) will receive a value of $158.98 per NASDAQ: LVGO shares they own.

However, given that at least one analyst has set the high target price for NASDAQ: LVGO at $170.00 per share, the investigation concerns whether the offer is unfair to NASDAQ: LVGO stockholders. More specifically, the investigation concerns whether the Livongo Health, Inc Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Livongo Health, Inc. reported that its annual Total Revenue rose from $417.9 million in 2018 to over $553.3 million in 2019.

Those who are current investors in Livongo Health, Inc. (NASDAQ: LVGO) shares have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.